Disc Medicine高管在电话会议中指出,关于加速审批途径的政策辩论已延续多届政府任期。近期监管机构的系列决策表明,其对适用加速审批标准的评估正变得"日益严格"。
Disc Medicine高管在电话会议中指出,关于加速审批途径的政策辩论已延续多届政府任期。近期监管机构的系列决策表明,其对适用加速审批标准的评估正变得"日益严格"。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.